Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.
about
Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsComplementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancerPathogenetic mechanisms in gastric cancer.MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection.Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study.Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithmGastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin.New guidelines for HER2 pathological diagnostics in gastric cancer.Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.Optimal management of resected gastric cancer.
P2860
Q27012898-21D3480A-A5FB-4CBF-9867-F1F98AD1B1B7Q33888813-FFE33B84-1FB7-45D0-846D-E46EA9895971Q34326627-54D6FA59-2F0E-4C19-B0FB-BA936C006535Q34977222-6FCEB9D0-2667-4400-92B7-09AFA4E6624AQ35051995-010731EE-FE9C-4E84-86FB-35CDB46AD6B8Q35815603-1AB38ED0-833B-4B52-A3CD-71CBFC8C4792Q36648866-B7A3C32F-9C82-475C-8BAD-46EE09CB0C1CQ37213524-7254FC85-154E-447E-8541-C6A6818C3D25Q37687784-1B66E677-D2E0-4550-9FBE-6D6BB507D2D5Q38527414-EDF326BD-F177-497F-AC32-2AAC17C0A053Q42290643-68D4E860-409C-4ECA-862E-A9299257F29DQ54219250-9D8EEC7D-3803-4D24-B177-A9892C7FD4AEQ55026328-B45684D7-CFE7-43D0-ABB5-89AFF9170AE7Q55281801-84DB6E04-D058-4567-BBF1-33E869C91B8DQ55359616-DB9457CF-E3F5-48D3-8B31-75425AD1F396
P2860
Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Prognostic implications of EGF ...... following curative resection.
@en
Prognostic implications of EGF ...... following curative resection.
@nl
type
label
Prognostic implications of EGF ...... following curative resection.
@en
Prognostic implications of EGF ...... following curative resection.
@nl
prefLabel
Prognostic implications of EGF ...... following curative resection.
@en
Prognostic implications of EGF ...... following curative resection.
@nl
P2093
P2860
P1433
P1476
Prognostic implications of EGF ...... following curative resection.
@en
P2093
Eun Jung Kim
Gil Hyun Kang
Heui June Ahn
Hyuk Jai Jang
Ji-Hoon Kim
Kwang Hoon Oh
Sang Jin Lee
Yong Chel Ahn
P2860
P2888
P304
P356
10.1007/S10120-013-0288-0
P50
P577
2013-08-17T00:00:00Z